Walnut Towers
211 S. Ninth Street, Suite 600
Philadelphia, PA 19107
(215) 955-1925
(215) 928-3160 fax
211 S. Ninth Street, Suite 600
Philadelphia, PA 19107
(215) 955-1925
(215) 928-3160 fax
Most Recent Peer-reviewed Publications
- Targeting renal glucose reabsorption for the treatment of type 2 diabetes mellitus using the SGLT2 inhibitor Dapagliflozin
- Subclinical hyperthyroidism: Current concepts and scintigraphic imaging
- Exenatide once weekly in type 2 diabetes mellitus
- Management of diabetes mellitus in the elderly
- 46, XX SRY-positive male syndrome presenting with primary hypogonadism in the setting of scleroderma
- Advantages of extended-release metformin in patients with type 2 diabetes mellitus
- Skin manifestations of hormone-secreting tumors
- The importance of reducing hyperglycemia while preserving insulin secretion-the rationale for sodium-coupled glucose co-transporter 2 inhibition in diabetes
- Visual vignette.
- Editorial: Type 2 diabetes and HbA1c goal: Time for individualised therapy
- A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS
- Endocrine incidentalomas
- Sodium glucose co-transporter 2 inhibitors: Blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes
- Primary care physicians and insulin initiation: Multiple barriers, lack of knowledge or both?
- Accuracy of bedside capillary blood glucose measurements in critically ill patients
- Scintigraphic imaging of body neuroendocrine tumors
- Hypoglycemia in hospitalized patients treated with antihyperglycemic agents
- Diabetes knowledge: Are resident physicians and nurses adequately prepared to manage diabetes?
- Endocrinology in dermatology
- Rare syndromes